HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Trilostane therapy for treatment of pituitary-dependent hyperadrenocorticism in 5 cats.

Abstract
Hyperadrenocorticism is a rare syndrome in cats. Current medical therapy is unsatisfactory and prognosis for long-term survival with surgical treatment is guarded. We report on 5 cats treated with the 3-beta hydroxysteroid dehydrogenase inhibitor trilostane. Diagnosis was confirmed in all cats by endocrine testing. Three cats had concurrent diabetes mellitus. Trilostane reduced clinical signs and improved endocrine test results in all cats, but insulin requirements did not change and all continued to have some signs of hypercortisolemia. Two died or were euthanized after 16 and 140 days, whereas 3 were still alive 6, 11, and 20 months after the start of trilostane therapy. Trilostane ameliorates clinical signs of feline hyperadrenocorticism, but more research is needed before it can be recommended for treatment.
AuthorsReto Neiger, Angela L Witt, Ann Noble, Alexander J German
JournalJournal of veterinary internal medicine (J Vet Intern Med) 2004 Mar-Apr Vol. 18 Issue 2 Pg. 160-4 ISSN: 0891-6640 [Print] United States
PMID15058766 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Enzyme Inhibitors
  • Dihydrotestosterone
  • 3-Hydroxysteroid Dehydrogenases
  • trilostane
Topics
  • 3-Hydroxysteroid Dehydrogenases (antagonists & inhibitors)
  • Administration, Oral
  • Adrenocortical Hyperfunction (drug therapy, veterinary)
  • Animals
  • Blood Chemical Analysis (veterinary)
  • Cat Diseases (blood, diagnostic imaging, drug therapy)
  • Cats
  • Dihydrotestosterone (administration & dosage, analogs & derivatives, therapeutic use)
  • Enzyme Inhibitors (administration & dosage, therapeutic use)
  • Female
  • Male
  • Treatment Outcome
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: